Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration LDL(-) in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1587-1592

  Mafra, Denise ^a,d   Santos, Felipe Rizzetto ^b   Lobo, Julie Calixto ^c   De Mattos Grosso, Daniela ^c   Barreira, André Luis ^b   Velarde, Luis Guillermo Coca ^a   Abdalla, Dulcinéia Saes Parra ^c   Leite, Maurilo ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d R Theodor Herzl   (Brazil)

Author keywords

tocopherol; Cardiovascular disease; Electronegative LDL; Haemodialysis

Indexed keywords

ALPHA TOCOPHEROL; AUTOANTIBODY; CHOLESTEROL; ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARM MUSCLE AREA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK REDUCTION; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

ADMINISTRATION, ORAL; ADULT; ALPHA-TOCOPHEROL; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHRONIC DISEASE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; KIDNEY DISEASES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 65249169297     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn760     Document Type: Article

References (50)

1. Stenvinkel P. New insights oninflammation inchronic kidney disease-genetic and non-genetic factors. Nephrol Ther 2006; 2: 111-119
2. Ece A, Gurkan F, Kervancioglu M et al. Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 2006; 21: 545-552
3. Gordon CA, Himmelfarb J. Antioxidant therapy in uremia: evidence-based medicine? Semin Dial 2005; 17: 327-332
4. Navab M, Berliner JA, Watson AD et al. The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol 1996; 16: 831-842
5. Tertov VV, Orekhov AN. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. Exp Mol Pathol 1997; 64: 127-145
6. Avogaro G, Bittolo-Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79-87
7. Sevanian A, Asatryan L, Ziouzenkova O. Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Blood Purif 1999; 17: 66-78
8. Bernitez S, Ordonez-Llanos J, Franco M et al. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor. Am J Cardiol 2004; 93: 414-420
9. Ziouzenkova O, Asatryan L, Akmal M et al. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood relevance to atherogenesis caused by hemodialysis. J Biol Chem 1999; 274: 18916-19924
10. Lobo J, Santos F, Grosso D et al. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Nephron Clin Pract 2008; 108: 298-304
11. Jialal I, Fuller CJ. Effect of vitamin E, vitamin C and beta carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995; 11: 97-109
12. Tucker JM, Townsend DM. Alpha-Tocopherol: roles on prevention and therapy of human disease. Biomed Pharmacother 2005; 59: 380- 387
13. World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Geneva: WHO, 1997, 362-374
14. Keys A, Fidanza F, Kcarvonen MJ. Indices of relative weight and obesity. J Chronic Dis 1972; 25: 329-343
15. Griffin BA, Caslake MJ, Yip B et al. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990; 83: 59-67
16. Hodis HN, Kramsch DM, Avogaro P et al. Biochemical and citotoxic characteristic of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res 2004; 35: 669-677
17. Damasceno N, Sevanian A, Apolinário E et al. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clin Biochem 2006; 39: 28-38
18. Thurnhan DI, Smith E, Flora OS. Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene and β-cryptoxanthin. Clin Chem 1988; 34: 337-343
19. Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 7: 1213- 1218
20. Amann K, Tornig J, Buzello M et al. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure. Kidney Int 2002; 62: 877-884
21. Badiou S, Cristol JP, Morena M et al. Vitamin E supplementation increases LDL resistance to ex vivo oxidation in hemodialysis patients. Int J Vitam Nutr Res 2000; 73: 290-296
22. Galli F, Zsuzsa V, Balla J et. al. Vitamin E, lipid profile, and peroxi-dation in hemodialysis patients. Kidney Int 2001; 1: 148-154
23. Morimoto H, Nakao K, Fukuoka K et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2775- 2782
24. Oliveira JA, Sevanian A, Rodrigues RJ et al. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes. Clin Biochem 2006; 39: 708-714
25. Gomes LF, Alves AF, Sevanian A. Role of beta2-glycoprotein I, LDL-, and antioxidant levels in hypercholesterolemic elderly subjects. Antioxid Redox Signal 2004; 6: 237-244
26. Bittolo-Bon G, Cazzolato G, Avogaro P. Probucol protects low-density lipoproteins from in vitro and in vivo oxidation. Pharmacol Res 1994; 29: 337-444
27. Vedie B, Jeunemaitre X, Megnien JL et al. Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the ApoB and CIII genes. Arterioscler Thromb Vasc Biol 1998; 18: 1780-1789
28. Tai MH, Kuo SM, Liang HT et al. Modulation of angiogenic processes in cultured endothelial cells by low density lipoproteins subfrac-tions from patients with familial hypercholesterolemia. Atherosclerosis 2006; 86: 448-457
29. Sanchez-Quesada JL, Benitez S, Franco M et al. Density distribution of electronegative LDL (LDL(-)) in normolipemic and hyperlipemic subjects. J Lipid Res 2002; 43: 699-705
30. Chen HH, Hosken BD, Huang M et al. Electronegative LDL from familial hypercholesterolemic patients are physico-chemically heterogeneous but uniformly proapoptotic. J Lipid Res 2006; 48: 177-184
31. Moro E, Alessandrini P, Zambo C. Is glycation of low density lipopro-teins in patients with type 2 diabetes mellitus a LDL pre-oxidative condition? Diabet Med 1999; 16: c-663-c-669
32. Sanchez-Quesada JL, Bernitez S, Perez A et al. The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetyl-hydrolase activity. Diabetologia 2005; 48: 2162-2169
33. Sanchez-Quesada JL, Perez A, Caixas A et al. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. J Clin Endocrinol Metab 2001; 86: 3243-3249
34. Yano M, Inoue M, Maehata E et al. Increased electronegative charge of serum low-density lipoprotein in patients with diabetes mellitus. Clin Chim Acta 2004; 340: 93-98
35. Bernitez S, Camacho M, Bancells C et al. Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta 2006; 1761: 1014-1021
36. Gambino R, Pisu E, Pagano G et al. Low-density lipoproteins are more electronegatively charged in type 1 than in type 2 diabetes mellitus. Lipids 2006; 41: 529-533
37. Yang CY, Chen HH, Huang MT et al. Pro-apoptotic low-density lipoprotein subfractions in type II diabetes. Atheroslcerosis 2007; 193: 283-291
38. Apolinário E, Ferdebar S, Pereira EC et al. Minimally modified (electronegative) LDL- and anti-LDL- autoantibodies in diabetes melli-tus and impaired glucose tolerance. Intern J Atherosclerosis 2006; 1: 42-47
39. Ziouzenkova O, Asatryan L, Tetta C et al. Oxidative stress during ex vivo hemodialysis of blood is decreased by a novel hemolipodialysis procedure utilizing antioxidants. Free Radic Biol Med 2002; 33: 248- 258
40. Lubrano R, Taccone-Gallucci M, Piazza A et al. Vitamin E supplementation and oxidative status of peripheral blood mononuclear cells and lymphocyte subsets in hemodialysis patients. Nutrition 1992; 8: 94-97
41. Panzetta O, Cominacini L, Garbin U et al. Increased susceptibility of LDL to in vitro oxidation in patents on maintenance hemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol 1995; 44: 303-309.
42. Roob JM, Khoschsorur G, Tiran A et al. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11: 539-549
43. Sato M, Matsumoto Y, Morita H et al. Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis patients without peripheral arterial disease. Clin Nephrol 2003; 60: 28-34
44. Clermont G, Lecour S, Cabane JF et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Radic Biol Med 2001; 31: 233-241
45. Triolo L, Malaguti M, Ansali F et al. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients. Artif Cells Blood Substit Immobil Biotechnol 2003; 31: 185-191
46. Yang CC, Hsu SP, Wu MS et al. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int 2006; 69: 706-714
47. Wanner C, Quaschning T. Dyslipidemia and renal disease: pathogen-esis and clinical consequences. Curr Opin Nephrol Hypertens 2001; 10: 195-201
48. Kalantar-Zadeh K, Kilpatrick RD, Kopple JD et al. A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Hemodial Int 2005; 9: 314-324
49. Ilam KN, O'Byrne D, Devaraj S et al. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 2000; 150: 217- 224
50. Khajehhehi P. Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand J Urol Nephrol 2000; 34: 62-66